SU559650A3 - Способ получени 1,4-бензодиазепинов - Google Patents
Способ получени 1,4-бензодиазепиновInfo
- Publication number
- SU559650A3 SU559650A3 SU2065465A SU2065465A SU559650A3 SU 559650 A3 SU559650 A3 SU 559650A3 SU 2065465 A SU2065465 A SU 2065465A SU 2065465 A SU2065465 A SU 2065465A SU 559650 A3 SU559650 A3 SU 559650A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- methylene
- chlorophenyl
- methyl
- benzodiazepine
- dihydro
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 5
- GUJAGMICFDYKNR-UHFFFAOYSA-N 1,4-benzodiazepine Chemical class N1C=CN=CC2=CC=CC=C12 GUJAGMICFDYKNR-UHFFFAOYSA-N 0.000 title 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 50
- -1 amine salt Chemical class 0.000 description 48
- 229910052801 chlorine Inorganic materials 0.000 description 21
- 239000000460 chlorine Substances 0.000 description 21
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 18
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 11
- 125000006295 amino methylene group Chemical group [H]N(*)C([H])([H])* 0.000 description 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 7
- 229910021529 ammonia Inorganic materials 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 7
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- 238000002211 ultraviolet spectrum Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 238000002329 infrared spectrum Methods 0.000 description 6
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 6
- 239000006260 foam Substances 0.000 description 5
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 229940049706 benzodiazepine Drugs 0.000 description 4
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- UQZIVIVFXNMLLC-UHFFFAOYSA-N 2h-1,4-benzodiazepine Chemical compound C1C=NC=C2C=CC=CC2=N1 UQZIVIVFXNMLLC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 2
- NSGCECVNIHAAIE-UHFFFAOYSA-N 2,3-dihydro-1h-1,4-benzodiazepine Chemical compound N1CCN=CC2=CC=CC=C21 NSGCECVNIHAAIE-UHFFFAOYSA-N 0.000 description 1
- GGVYNUIXICATSY-UHFFFAOYSA-N 2-methyl-2H-1,4-benzodiazepine Chemical compound CC1N=C2C(=CN=C1)C=CC=C2 GGVYNUIXICATSY-UHFFFAOYSA-N 0.000 description 1
- RIUPGPYCWKJQKQ-UHFFFAOYSA-N 3-(aminomethylidene)-7-bromo-5-(2-chlorophenyl)-1-methyl-1,4-benzodiazepin-2-one Chemical compound N=1C(=CN)C(=O)N(C)C2=CC=C(Br)C=C2C=1C1=CC=CC=C1Cl RIUPGPYCWKJQKQ-UHFFFAOYSA-N 0.000 description 1
- XZTLRPIGSGBZSI-UHFFFAOYSA-N 3-(butylaminomethylidene)-5-(2-chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2-one Chemical compound C12=CC([N+]([O-])=O)=CC=C2NC(=O)C(=CNCCCC)N=C1C1=CC=CC=C1Cl XZTLRPIGSGBZSI-UHFFFAOYSA-N 0.000 description 1
- WPFUFWIHMYZXSF-UHFFFAOYSA-N 4-[2-(difluoromethyl)benzimidazol-1-yl]-n-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine Chemical compound C1CN(C)CCC1C1=CC=CC=C1CC(C)(C)NC1=NC(N2CCOCC2)=NC(N2C3=CC=CC=C3N=C2C(F)F)=N1 WPFUFWIHMYZXSF-UHFFFAOYSA-N 0.000 description 1
- KDTVWEHAAISPNW-UHFFFAOYSA-N 4-methylthiomorpholine Chemical compound CN1CCSCC1 KDTVWEHAAISPNW-UHFFFAOYSA-N 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical group C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical compound CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- UDGSVBYJWHOHNN-UHFFFAOYSA-N n',n'-diethylethane-1,2-diamine Chemical compound CCN(CC)CCN UDGSVBYJWHOHNN-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19722234150 DE2234150A1 (de) | 1972-07-12 | 1972-07-12 | Neue 1,4-benzodiazepine |
| DE2324962A DE2324962A1 (de) | 1973-05-15 | 1973-05-15 | Neue 1,4-benzodiazepine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU559650A3 true SU559650A3 (ru) | 1977-05-25 |
Family
ID=25763551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU2065465A SU559650A3 (ru) | 1972-07-12 | 1974-10-09 | Способ получени 1,4-бензодиазепинов |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3872090A (enExample) |
| BG (1) | BG20599A3 (enExample) |
| CH (1) | CH590854A5 (enExample) |
| ES (1) | ES422319A1 (enExample) |
| FR (1) | FR2191906B1 (enExample) |
| NL (1) | NL7309651A (enExample) |
| PH (1) | PH10572A (enExample) |
| PL (1) | PL92135B1 (enExample) |
| SU (1) | SU559650A3 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2502621B1 (enExample) * | 1981-03-27 | 1983-10-28 | Roussel Uclaf |
-
1973
- 1973-07-05 US US376378A patent/US3872090A/en not_active Expired - Lifetime
- 1973-07-06 PH PH14798A patent/PH10572A/en unknown
- 1973-07-09 CH CH1370876A patent/CH590854A5/xx not_active IP Right Cessation
- 1973-07-10 BG BG26529A patent/BG20599A3/xx unknown
- 1973-07-11 NL NL7309651A patent/NL7309651A/xx unknown
- 1973-07-11 PL PL1973178210A patent/PL92135B1/pl unknown
- 1973-07-12 FR FR7325606A patent/FR2191906B1/fr not_active Expired
-
1974
- 1974-01-16 ES ES422319A patent/ES422319A1/es not_active Expired
- 1974-10-09 SU SU2065465A patent/SU559650A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| ES422319A1 (es) | 1976-04-16 |
| PL92135B1 (enExample) | 1977-03-31 |
| FR2191906A1 (enExample) | 1974-02-08 |
| NL7309651A (enExample) | 1974-01-15 |
| BG20599A3 (enExample) | 1975-12-05 |
| US3872090A (en) | 1975-03-18 |
| CH590854A5 (enExample) | 1977-08-31 |
| PH10572A (en) | 1977-06-30 |
| FR2191906B1 (enExample) | 1976-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sternbach | 1, 4‐benzodiazepines. Chemistry and some aspects of the structure‐activity relationship | |
| US4280957A (en) | Imidazodiazepines and processes therefor | |
| US3701782A (en) | 1-carbolower alkoxy - 6 - phenyl-4h-s-triazolo(1,4)benzodiazepine compounds | |
| US3299053A (en) | Novel 1-and/or 4-substituted alkyl 5-aromatic-3h-1, 4-benzodiazepines and benzodiazepine-2-ones | |
| FI63234C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 6-enyl-4h-imidazo(1,5-a)(1,4)diazepinfoereningar | |
| CA1157855A (en) | Benzodiazepine derivatives | |
| SU559650A3 (ru) | Способ получени 1,4-бензодиазепинов | |
| Tanaka et al. | Axial chirality and affinity at the GABAA receptor of triazolobenzodiazepines | |
| US4401597A (en) | Imidazodiazepines and processes therefor | |
| US3340253A (en) | Preparation of certain benzodiazepine compounds | |
| US4440685A (en) | Imidazodiazepines and processes therefor | |
| US3757008A (en) | Sses for preparing same 1 - (carboxyl-heteroalkyl) - 1,4-benzodiazepine derivatives and proce | |
| US4347364A (en) | Imidazodiazepines | |
| US4347365A (en) | Imidazodiazepines | |
| US3523947A (en) | 1-cyclic amidine-5-aryl-1,4-benzodiazepine and process | |
| US4377523A (en) | Imidazodiazepines and processes therefor | |
| Kobayashi | Pyrimidine-Fused 1, 4-Benzodiazepines. Reaction of 1, 4-Benzodiazepines with Formamide–POCl 3 | |
| MEGURO et al. | Heterocycles. IV. Reactions of 2-Amino-3H-1, 4-benzodiazepines with Primary Amines and Hydroxylamines | |
| JPS6249273B2 (enExample) | ||
| US3513158A (en) | Process for preparing 5-aryl benzodiazepines and intermediates | |
| US4349477A (en) | Process for producing imidazodiazepines | |
| US4073785A (en) | Certain as-triazino 4,3-a! 1,4!benzodiazepine derivatives | |
| US4368157A (en) | Intermediates to produce imidazodiazepines | |
| US4368159A (en) | Intermediates to produce imidazodiazepines | |
| FI66384C (fi) | Vid framstaellning av terapeutiskt anvaendbara 6-fenyl-4h-imidazo(1,5-a)(1,4)-diazepinfoereningar saosom mellanprodukter anvaendbara 3a 4-dihydroimidazo(1,5-a)(1,4)diazepinderivat |